New Massive Sulphide Mineralization FoundTORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Sparton Resources Inc. (TSXV-SRI) ("Sparton" or the "Company”) announced today that field operations are underway at the Pense Critical Metals Project near Englehart in Northern Ontario and Quebec. The Pense mineralization exhibits many similarities to the world-class Outokumpu deposits in Finland. Results of the initial drill program and Ontario Junior Exploration Program (“OJEP”) funding assistance at Pense on the Ontario ...

SASKATOON, Saskatchewan, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the signing of a definitive share purchase agreement to acquire a 100% interest in a PharmaChoice Canada bannered pharmacy business located in Ontario (the “Acquisition”). This transaction marks PharmaCorp’s first acquisition under its charter company structure, which was established through the purchase completed on April 30, 2025. In addition, PharmaCorp ha ...

Phase 3 trial to evaluate two subcutaneous BRIUMVI dosing regimensNEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has commenced in a Phase 3 trial evaluating subcutaneous BRIUMVI (ublituximab-xiiy), the company’s anti-CD20 monoclonal antibody, in people with relapsing forms of multiple sclerosis (RMS). BRIUMVI is currently approved in the United States, as well as several ex-US territories, as a one-hour intravenous (IV) infusion administere ...

TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) today announced its Xtract One Gateway (“Gateway”) system has been selected by Delmar School District in Delmar, Delaware to strengthen protection of its middle and high school building entrances, with system installation set for the fall semester. In selecting Xtract One, Delmar School District is fostering a secure and welcoming experience for students, staff, and visit ...

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –Vancouver, BC & Edinburgh, Scotland, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce that it has made its first strategic software investment into RideScan Ltd ( ...

WASHINGTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Shaun Rangappa, MD, MSHA, as a Senior Managing Director in the Healthcare Business Transformation practice within the firm’s Corporate Finance & Restructuring segment. A graduate of the University of Virginia School of Medicine, Dr. Rangappa brings over 30 years of experience in healthcare, spanning clinical practice, clinical process evaluation and performance improvement, technology enablemen ...

TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to provide an update on drilling and development activities at the Company’s Mercur Gold Project (“Mercur” or, the “Project”) located in Utah, U.S.A. Drilling Highlights Two rigs operating at Mercur since July have completed approximately 3,200 meters of a planned 13,000-meter drilling program at Mercur this year.Six PQ core holes have been drilled to collect material from the ...

Harvia Plc, Stock Exchange Release, September 8, 2025 at 2.30 PM EEST Composition of the shareholders’ nomination board of Harvia Plc Harvia Plc’s shareholders’ nomination board prepares proposals concerning the election and remuneration of the Board Members as well as the remuneration of the members of the various Board committees that will be submitted to future Annual General Meetings and to any Extraordinary General Meetings where necessary. The shareholders’ nomination board will be comprised of repres ...

Core Insights - Exodus Movement, Inc. is considering a potential quarterly Bitcoin dividend for shareholders, supported by an increase in its Bitcoin treasury [4] - As of August 31, 2025, Exodus holds 2,116 BTC, up from 2,087 BTC in July 2025, indicating operational strength [1] - The company reported a decrease in Monthly Active Users (MAUs) to 1.6 million in August 2025 from 1.7 million in July 2025 [2] - Exchange provider processed volume for August 2025 was $572 million, down from $632 million in July 2025, with a consistent contribution from XO Swap partners [3] Digital Asset Holdings - Bitcoin (BTC): 2,116 BTC as of August 31, 2025, compared to 2,087 BTC as of July 31, 2025 [1] - Ethereum (ETH): 2,756 ETH as of August 31, 2025, compared to 2,742 ETH as of July 31, 2025 [1] - Solana (SOL): 43,738 SOL as of August 31, 2025, compared to 34,578 SOL as of July 31, 2025 [1] User Metrics - Monthly Active Users (MAUs): 1.6 million as of August 31, 2025, down from 1.7 million in July 2025 [2] - Passkeys wallets: Approximately 11,000 as of August 31, 2025, compared to 20,000 in July 2025 [2] Exchange Volume - Processed volume for August 2025: $572 million, down from $632 million in July 2025 [3] - XO Swap partners contributed $149 million (26%) to the August volume, compared to $149 million (24%) in July [3]

Core Insights - Insight Molecular Diagnostics, Inc. (iMDx) announced a positive strategic update regarding its kidney transplant rejection assay and the establishment of a novel registry to collect real-world data on patient experiences and outcomes [1][2] Company Developments - The company plans to enroll 5,000 patients across at least 25 centers over three years, aiming to support the clinical utility of its unique assay and an accelerated monitoring protocol for high-risk patients [2][3] - CEO Josh Riggs highlighted the significance of the registry as a supportive data repository and expressed optimism about centers transitioning to in-house testing post-regulatory clearance [3] - CFO Andrea James emphasized the alignment of the registry rollout with the company's growth strategy and revenue generation plans at its Nashville lab [3] Industry Context - The registry announcement follows key developments, including claims expansion for dd-cfDNA testing in CLIA certified labs and an increased reimbursement rate for GraftAssureCore to $2,753 per result by CMS [3][4] - Late-breaking data presented at the World Transplant Congress indicated improved positive predictive value (PPV) for graft rejection, leading to fewer false positives and reduced invasive biopsies [3][4] Technological Innovations - iMDx has introduced two critical clinical innovations: the Berlin Protocol for testing frequency in high-risk patients and an algorithmic approach to enhance biopsy yields [4][6] - The company aims to deliver a best-in-class molecular diagnostic test kit, targeting an estimated $1 billion addressable market for transplant rejection testing [4][6] Product Overview - iMDx's flagship technology quantifies donor-derived cell-free DNA (dd-cfDNA), a biomarker for transplant rejection, and is commercialized under the GraftAssure™ brand [7][8] - The GraftAssureCore test is currently reimbursed by CMS and performed at the company's CLIA-certified laboratory in Nashville, with plans to rebrand the VitaGraft assay under this name [11]